{"name":"Faron Pharmaceuticals Ltd","slug":"faron-pharmaceuticals-ltd","ticker":"","exchange":"","domain":"faron.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirwJBVV95cUxNeGtvZUphZEVOWlBPNzJIeVBTSWRHOWpsWW9XOWhBOXF1X1VTYlFxc0Q2U2VVNl9YbC1GS0p2R3R0RDYtdk83bUdkQ2tUV1MzSDhpcTcyVzd2TzIyWUUwOGx5TXhoTGxtZ09MYkx2NWxxc2c4cjJsR19nOVFhZG1Xd3haMTVLbTNsTzRENnhta2RrRXNjLVVqLVhXWVU5V2tFOThwT0gyTmpiVEtPYTF0QWVJaDh5bEJWRk1pVEp1LWJmMlVpcWYxejY0TzRnSGhrVDJpY2NHenlQNjNKUk9zcjdfamliNjZaZnQtaWdIcXoxR0VZLWNKdzZHNW10d0RDTjREbm1tR1hQY3hLbDY3NXRRSU1qTHhhdzhJcnVxLTIyQXNiem1jQU5qdVZyYzQ?oc=5","date":"2026-03-26","type":"pipeline","source":"The Norfolk Daily News","summary":"Faron Pharmaceuticals Ltd: Faron Appoints New CTO to Strengthen Late-Stage Development Activities - The Norfolk Daily News","headline":"Faron Pharmaceuticals Ltd: Faron Appoints New CTO to Strengthen Late-Stage Development Activities","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxONVpEUGR3R3JWdDhic2hSZkdTT2N0cU8zUVU5TjFrRmxFMFR3elJWSWduSVNkS0tnLUxSbVpIVi1MelhNSlh4cEM1YlplYTdqWWp4TnU1R0lDenJacFBXc215MnlxVlJIQkRjZC0yUWVuc2M4amdVd0pfSUk1MkEtQ1dPS2ZRZFNTU2IxX1NkWU9jQmctMHNDLVFqTE5FdE5fVW1zTFUtLW1nVDZ3VXJYS1FtWER6Qzg4d0M1UURSR3ZoTnRxVmVHV2ZOUTl0cU82dWduTzk2YjRrT0s3QWdOTQ?oc=5","date":"2026-03-26","type":"pipeline","source":"PharmiWeb.com","summary":"Faron Pharmaceuticals Ltd: Faron Appoints New CTO to Strengthen Late-Stage Development Activities - PharmiWeb.com","headline":"Faron Pharmaceuticals Ltd: Faron Appoints New CTO to Strengthen Late-Stage Development Activities","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxON2tPZE5WSm1XUGFIMUZOS0xEWGlya3k3Tktaa2RHT2Naem9XUHVQTG1hZFMyaWhMQm93eXk0dFFBODkyWC1wWTBVTHVZYUg5UWw2U3BTbUVwbl9VcENWNm1yVUU2MjAzMWJVdUl2V2YzNzU4dDZaMXNfNnF4ekViT04tbkZySzM2d3FVX19GZzNxTGJOOFdmYU1BelZ0U1ROSFFsQ0tkckhkOWhZd0FsZ2FQb3lSWVNuVnpGSk9IWnVWdG4zUU1aaktB?oc=5","date":"2026-03-14","type":"trial","source":"Proactive Investors","summary":"Faron Pharma Plans €40m raise for Bexmarilimab trial - ICYMI - Proactive Investors","headline":"Faron Pharma Plans €40m raise for Bexmarilimab trial - ICYMI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxQVmpJY3Rtc0xwYXhBZnV2eWd5SVJBLVZKcFc0OXFzTGRuR2k5Wm9HRHFsYzN4Q1F3U0F4MTlWcnFRMEVCUG1rN0xSMTBYdUF1cm5Cd0VHUVBCNDRYbXlHUW5NeDQ5VXktSThKQ3NqTzZLWHpPT0hwODlMYjdEODZIdTF4UlFXZTZOSzNTNEtldjdKWm8xWmMySGc4eHZTdUdqSlhieHAwNU54ZmRTTW1zUDVvMTR4U3dNV0h2d0FoNjdnb3BPMkZWRDZQSkV1cDJMN1JmbGVJekU3VzYtUXd4Sm4tX0lVZXlqQ0g0?oc=5","date":"2026-03-04","type":"trial","source":"Proactive Investors","summary":"Faron Pharma says partnership talks continue as blood cancer drug data strengthens - Proactive Investors","headline":"Faron Pharma says partnership talks continue as blood cancer drug data strengthens","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQR1BzQXJTOXpVaDNvWk10cGpKdTBYVTJ0SGY1MVRyaTBiUnJVZGZmU3BKSzBCMkNJVEV2aEdTQXhId2hEakVlbUl2OTE5c0V6N1VUUzlEZFZYcUhJM1hIckpaMDJkc3pkU3NYc1dYa3dxeUkxRUlsMkRjLU1KUnNCUkxmMGxUTkppenAtMlhXclg?oc=5","date":"2026-03-04","type":"pipeline","source":"Yahoo Finance UK","summary":"AIM Market Roundup: MobilityOne, Surface Transforms, Faron Pharma - Yahoo Finance UK","headline":"AIM Market Roundup: MobilityOne, Surface Transforms, Faron Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9ncWVwWEFZcngxUloxUHBxSjItS2NZeGdvdDREQjZmY3pnVk9sQ1kxTFRSY0RHRXhrMHdDNnUyMEpGVHFHVUV0b2VUZGFNR1R1SEhr?oc=5","date":"2025-12-17","type":"pipeline","source":"FirstWord Pharma","summary":"Composition of Faron Pharmaceutical’s Shareholders’ Nomination Board - FirstWord Pharma","headline":"Composition of Faron Pharmaceutical’s Shareholders’ Nomination Board","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTE1MbGNmTEJyWEJvWlg4SlQ4M3MzQi1URVlwbGdTRS1yZ201QXlfb3A3WnlEa3pUTzNRLXRlaFlMdy1KVUJURVpnTXJTUDBjbm4xSlR2Ug?oc=5","date":"2025-12-03","type":"pipeline","source":"Pharmafile","summary":"Faron Pharmaceuticals appoints Jurriaan Dekkers as Chief Financial Officer - Pharmafile","headline":"Faron Pharmaceuticals appoints Jurriaan Dekkers as Chief Financial Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOMTNacGRRWGY2cThGUFY0UTBKOHZ1OTdERlF3Z3B1V1FOU2gyNzdLb0FYUU9pZVVrOERaSVNUZTBxd21US1hoYkVWdzZXaE1BZTFUNzNRaUNfejc3U2liVTRwb1NNTUZfM0dXdHk2al9Xd0xCdm9MRHRMa2xaZEdBcXhUZHF4dy1yRUpES2pPaG0ybGlHWU5ZTkp6UUFia0V1b0Rmb3AtS0tYR3FnNmFaUS1fNGFlQ2Vqc0JUVkFsTjE4TEFl?oc=5","date":"2025-08-18","type":"regulatory","source":"Proactive financial news","summary":"Faron Pharma up 5% on FDA clearance for pivotal trial - Proactive financial news","headline":"Faron Pharma up 5% on FDA clearance for pivotal trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOOWN1cFpkSC1uMFkxbVB4RnNSbnFvVVM4d3VlU0VWS0NCY000RmdEMXJFampXTGxTRVVZMmZhSjFQT1I3YUk4aUo5T3pIQ1dBaENTcHNOME1xY1Z4QlV6TEpjQjhydU1WU1VFaHVReFk2Wkh2Z2FrdzdjRzhBN0p3UVNMd2lvMTBFZk9NcndyOHB3Uk9pRllIWmdPMXF6c0RHeXdqQzg1SnhoSXBRRWFrN3U0ZHR5QzkxM1V1anJaaXdiWFk?oc=5","date":"2025-08-18","type":"regulatory","source":"Proactive Investors","summary":"Faron Pharma up 5% on FDA clearance for pivotal trial - Proactive Investors","headline":"Faron Pharma up 5% on FDA clearance for pivotal trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxOMFNHdUtBWkFqelBTbFBrYWctMjNVa1prM2hkOWk5ZjU5S0tHVkcxSzJtYXdOQXVqaEZqRUEyTXpxbXdiUlFlS25sMlhkWDVLdWhtRW1KLXctQ3hjY25zOUdEUnQ5Q0lEXzY1anBCUnMzYkNrOFVXcjlkSzNoanJUSjBBR0xPZ09Ca1JwbGdtNDRrV1F1T0ExUU5mWHkzTk5lX05hcEk0dVZ5a1lHXzR1Ul93ckhvakxYem5Vc25ydTBJRlg5Rm5fVWxWcENCbjJzaWtpcWxqcnBDZlVUVGNzaUNLcGNudHhDb3c?oc=5","date":"2025-01-26","type":"pipeline","source":"Citeline News & Insights","summary":"Faron CEO Discusses Potential “Game Changer” For High-Risk MDS Patient Population - Citeline News & Insights","headline":"Faron CEO Discusses Potential “Game Changer” For High-Risk MDS Patient Population - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOLXFlTUVxWXoyc21FRnN3Tjh6RXRUek04MUZFOFZtalU4N3BHejBDbFdHM0JpQ3R4WlQ2ZVJfYU96TXhWM3JfSUMtVE5OVTJiYWN1d2E1emh0dW9iWDcxOFpDTnUwa1dQTS0tQnE2eWs5cHkwYk9ZWFd6OHh0bm1HUFlmbldldTc3bTVDcUg1SG5heGFWZ0E2MWNfYWFYd1UycmRLcUNfT2ZxNDhzOVFLT3otcWVqOHR1UHdrbjJkNA?oc=5","date":"2024-12-02","type":"pipeline","source":"Pharmaceutical Technology","summary":"Faron Pharma secures UK innovation passport for blood cancer immunotherapy - Pharmaceutical Technology","headline":"Faron Pharma secures UK innovation passport for blood cancer immunotherapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxNNDFIS1pXb0N6Y2Roa0VmN2pzX2c5SURFbnpuRWFkZldteUx1WkJDTVRQUGpYd0VQT1kycVMzMjVxS3pXTk5EZHl5TW42WkZjaFlBWHJYMUlSZFFhM2pfbWd5RE85TFFhRWVIU3k0ajVXaHNHMFBaeXVkOUNKNTV1RnZibEw3V25uX25VMFE3a3NCSGZaZHMwMVdDSjFxbXlFTExKa0ZRT0pJVXFHeEtzN01rQnh3VzVRRXB3WVlSSE9pbkdOVG1RbW10NHpjM005cS1FckhnX0xrT3E1QUxFbDNRcThLdmVYUEdz?oc=5","date":"2023-12-07","type":"pipeline","source":"proactiveinvestors.com","summary":"Faron Pharma details cancer drug's impressive early results in peer-reviewed journal - proactiveinvestors.com","headline":"Faron Pharma details cancer drug's impressive early results in peer-reviewed journal","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}